To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
HEADS OF FACULTY
Small cell lung cancer (SCLC) is a highly aggressive disease, which initially responds to DNA damaging chemotherapy (cisplatin or carboplatin paired with the topoisomerase II inhibitor etoposide in first line, and topoisomerase I inhibitors [...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
1 Recommendation, most recent by
Past 7 Days
New Articles Recommended
Past 30 Days
13Articles Classified As Novel Drug Target670 total
7Articles Classified As Good for Teaching810 total
14Articles Classified As Interesting Hypothesis1,333 total
6Articles Classified As Confirmation2,217 total
3Articles Classified As Review / Commentary496 total
13Articles Classified As Technical Advance714 total
37Articles Classified As New Finding5,669 total
Get instant access to Article Recommendations from more than 8,000 leading experts in Biology and Medicine by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.